Richard Nolan Townsend, CEO: Lexeo Therapeutics LXEO Sell · Filed 02/20

Trade details

Type: Insider sale
Amount: $64,903.74
Shares · price: 10,173 sh · $6.38 a share
Held after: 392,483 sh
Stock: Lexeo Therapeutics LXEO
Person: Richard Nolan TownsendCEO
Trade date: 26/02/18
Filed: 26/02/20
Days to filing: 2 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Richard Nolan Townsend's recent trades

Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.6K
3,345 sh
$16.6K
Filed 08/18
Traded 08/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$116.2K
25,947 sh
$116.2K
Filed 07/01
Traded 07/01
Richard Nolan TownsendCEO
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/20
Traded 05/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/18
Traded 05/18
Richard Nolan TownsendCEO
Sell10b5-1 planLexeo Therapeutics
Sell10b5-1 plan
Lexeo Therapeutics
LXEO
$313K
55,000 sh
$313K
Filed 04/07
Traded 04/06